Frontken Berhad Annual Report 2017

41 Frontken Corporation Berhad (651020-T) ANNUAL REPORT 2017 DIRECTORS The following names of directors served on the Board of the Company during the financial year and up to the date of this report: Ng Wai Pin Dr. Tay Kiang Meng Dato’ Haji Johar Bin Murat @ Murad Aaron Sim Kwee Lein Dr. Jorg Helmut Hohnloser Timo Fabian Seeberger (Alternate to Dr. Jorg Helmut Hohnloser) (resigned on 24 August 2017) The names of directors of the Company’s subsidiaries who served during the financial year and up to the date of this report, not including those directors mentioned above, are as follows:- Hee Kok Hiong Sia Chiok Meng Lee Boon Tian Mohd. Shukri Bin Hitam Fauziah Binti Hamlawi  Mok Siew Wai George I.Lagos Andres Seno Jr. Glenn A.Lagos Wong Tong Lok DIRECTORS’ INTERESTS According to the register of directors’ shareholdings, the interests of directors holding office at the end of the financial year in shares in the Company and its related corporations during the financial year are as follows: Number of ordinary shares Balance as of 1.1.2017 Bought Sold Balance as of 31.12.2017 Shares in the Company Direct Interests Ng Wai Pin 5,000,000 1,000,000 - 6,000,000 Dr. Tay Kiang Meng 9,404,808 - - 9,404,808 The other directors holding office at the end of the financial year had no interests in the shares of the Company or of its related corporations during the financial year. DIRECTORS’ BENEFITS Since the end of the previous financial year, no director has received or become entitled to receive any benefit (other than a benefit included in the aggregate amount of remuneration received or due and receivable by directors shown in the financial statements or fixed salary of a full-time employee of the Company or related corporations) by reason of a contract made by the Company or a related corporation with the director or with a firm of which the director is a member, or with a company in which the director has a substantial financial interest except for any benefits which may be deemed to arise from transactions entered into in the ordinary course of business with companies in which certain directors have substantial financial interests as disclosed in Note 17 to the financial statements. Neither during nor at the end of the financial year was the Group or the Company a party to any arrangements whose object is to enable the directors to acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate. Directors’ Report (cont’d)